Manickam M

References (2)

Title : Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19 - Manickam_2021_Arch.Pharm.(Weinheim)__e2100367
Author(s) : Manickam M , Meenakshisundaram S , Pillaiyar T
Ref : Arch Pharm (Weinheim) , :e2100367 , 2021
Abstract : Manickam_2021_Arch.Pharm.(Weinheim)__e2100367
ESTHER : Manickam_2021_Arch.Pharm.(Weinheim)__e2100367
PubMedSearch : Manickam_2021_Arch.Pharm.(Weinheim)__e2100367
PubMedID: 34802171

Title : Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase - Manickam_2016_Eur.J.Med.Chem_117_113
Author(s) : Manickam M , Pillaiyar T , Boggu P , Venkateswararao E , Jalani HB , Kim ND , Lee SK , Jeon JS , Kim SK , Jung SH
Ref : Eur Journal of Medicinal Chemistry , 117 :113 , 2016
Abstract : Manickam_2016_Eur.J.Med.Chem_117_113
ESTHER : Manickam_2016_Eur.J.Med.Chem_117_113
PubMedSearch : Manickam_2016_Eur.J.Med.Chem_117_113
PubMedID: 27092411
Gene_locus related to this paper: human-EPHX2